What is the International Keratoconus Academy (IKA)?
Updated
The International Keratoconus Academy (IKA) is an international professional academy focused on keratoconus and other corneal ectatic diseases. According to its website, it pursues an educational and scientific mission through scientific meetings, continuing education programs, webinars, online educational resources, peer-reviewed publications, and collaborative clinical research. It is aimed at clinicians and researchers who diagnose and manage corneal ectatic disease, rather than at patients seeking direct care.
What IKA does
IKA describes its role as translating emerging scientific evidence into practical clinical recommendations and building consensus on the diagnosis and management of corneal ectatic disease. Its work falls into four visible areas:
- Education and meetings — scientific meetings, continuing education, webinars, and online resources.
- Clinical guidance — converting research findings into practical recommendations for diagnosis and management.
- Research — clinical, translational, and outcomes-based research, plus multidisciplinary collaboration and dissemination of evidence.
- Pediatric keratoconus — a dedicated initiative on early identification and treatment in children and adolescents.
Focus on corneal cross-linking and early intervention
One of IKA's stated primary educational priorities is corneal cross-linking. The Academy says it has promoted a shift away from the historical practice of observing patients until disease progression is documented, toward early diagnosis and intervention before irreversible structural damage and vision loss occur. It promotes evidence-based treatment algorithms that incorporate corneal cross-linking at the earliest appropriate stage, with the stated goals of preserving vision and reducing the long-term need for corneal transplantation.
This is a position the organization advocates; whether and when cross-linking is appropriate for a given patient is a clinical decision made by a treating eye care professional.
Pediatric keratoconus initiative
IKA notes that keratoconus in children is frequently more aggressive and progresses more rapidly than in adults, and it emphasizes early identification and treatment in pediatric patients. The Academy advocates routine risk assessment and the use of advanced corneal imaging—including Scheimpflug tomography and optical coherence tomography (OCT)—when evaluating children and adolescents at increased risk for ectatic disease. The stated rationale is that early diagnosis allows timely cross-linking during the years of visual development.
Research articles and evidence base
The site lists research articles, including studies on the prevalence of keratoconus based on Scheimpflug corneal tomography metrics, one in a pediatric population and one using updated metrics. It also highlights a pediatric prevalence study by Harthan et al. These listings are a way to see what evidence the Academy is discussing; the underlying papers, not the summaries, are the source for specific figures and methods.
Annual symposium
IKA holds an annual keratoconus symposium. The site lists the 4th Annual IKA Keratoconus Symposium as taking place Saturday, December 12, 2026, in Dallas, Texas, with details at ikasymposium.com. For current dates, registration, and program information, check that site directly, since event details can change.
Who it is useful for
| Reader | Likely value |
|---|---|
| Eye care clinicians (optometrists, ophthalmologists) | Continuing education, consensus-oriented clinical recommendations, cross-linking and pediatric guidance |
| Researchers | Collaborative and translational research, peer-reviewed publications, scientific meetings |
| Students and trainees | Webinars, online educational resources, symposium content |
| Patients and families | General orientation to the field and to why early detection is emphasized; not a substitute for care from a treating clinician |
The site does not state pricing or membership terms in the material available here, so check the site itself for access conditions to meetings, webinars, and publications.